ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
NCT04609111
·
clinicaltrials.gov ↗
PHASE4
Phase
ACTIVE_NOT_RECRUITING
Status
6002
Enrollment
OTHER
Sponsor class
Conditions
Acute Coronary Syndrome
Interventions
DRUG:
No aspirin
DRUG:
1-month DAPT
Sponsor
Kyoto University, Graduate School of Medicine